QuantiFERON-TB Gold Plus at Test Zone Diagnostic Center

QuantiFERON-TB Gold Plus at Test Zone Diagnostic Center

The QuantiFERON-TB Gold Plus (QFT-Plus) test at Test Zone Diagnostic Center is a state-of-the-art, highly accurate blood test used to detect infection with Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). As an Interferon-Gamma Release Assay (IGRA), this advanced diagnostic tool represents a major technological leap over the traditional Tuberculin Skin Test (TST). It measures the body’s cell-mediated immune response to specific tuberculosis antigens. By analyzing how a patient’s T-lymphocytes react to these antigens in a controlled laboratory environment, the test can identify both latent tuberculosis infection (LTBI) and active tuberculosis disease. This diagnostic evaluation is critical for patients requiring screening due to occupational exposure, clinical symptoms, or prior to initiating immunosuppressive medical therapies.

Understanding the clinical importance of the QuantiFERON-TB Gold Plus test requires looking at its underlying technology. Unlike older skin tests, which require patients to return to a clinic multiple times and are highly susceptible to subjective interpretation errors, the QFT-Plus is a modern, single-visit blood test. It utilizes advanced enzyme-linked immunosorbent assay (ELISA) technology to quantify the concentration of interferon-gamma (IFN-γ) released by T-cells. This cellular response is highly specific to Mycobacterium tuberculosis. The test evaluates both CD4+ and CD8+ T-cell responses, providing a comprehensive immunological profile. This dual-pathway evaluation significantly improves diagnostic sensitivity, particularly in immunocompromised patients, elderly individuals, and young children, making it an invaluable diagnostic tool for clinicians across various medical specialties.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the clinical accuracy of the QuantiFERON-TB Gold Plus test at Test Zone Diagnostic Center. Patients should follow these guidelines before their blood draw:

• No Fasting Required: There is no medical requirement to fast before this test. Patients may eat and drink normally prior to their appointment.
• Medication Disclosure: Patients must inform the laboratory staff and their referring physician of all current medications, especially corticosteroids, biologics, chemotherapy, or other immunosuppressive drugs, as these can affect immune cell reactivity.
• Timing with Vaccines: It is highly recommended to perform the blood draw either before or at least four to six weeks after receiving live virus vaccines (such as MMR or varicella) to prevent temporary suppression of cellular immunity.
• Hydration: Being well-hydrated is recommended to facilitate an easier venipuncture process.
• Identification and Paperwork: Patients should bring their doctor’s prescription, a valid national identity card, and any previous TB screening records.

During the Procedure

The blood collection process for the QuantiFERON-TB Gold Plus test is highly specialized and follows strict laboratory protocols to maintain sample viability:

• Patient Positioning: The patient is seated comfortably in a blood collection chair, and the phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm.
• Specialized Collection Tubes: Unlike standard blood tests, the QFT-Plus requires blood to be drawn directly into four specialized, color-coded tubes in a specific order: Nil (Grey), TB1 (Green), TB2 (Yellow), and Mitogen (Purple).
• Precise Tube Filling: Each tube must be filled to the designated black mark on the side (exactly 1.0 mL of blood) to ensure the correct ratio of blood to the chemical antigens coated on the tube walls.
• Immediate Mixing: Immediately after drawing, the phlebotomist must gently shake all four tubes exactly ten times to ensure the antigens dissolve and mix thoroughly with the blood.
• Temperature Control: The samples must be kept at room temperature and transferred to an incubator at 37 degrees Celsius within 16 hours of collection to initiate the cellular reaction.
• Safety and Comfort: The venipuncture takes less than five minutes, is virtually painless except for a mild pinch, and is performed under strict aseptic conditions.

When is a QuantiFERON-TB Gold Plus Performed?

1. Screening for Latent Tuberculosis Infection (LTBI)

Physicians request the QuantiFERON-TB Gold Plus test to identify individuals who are infected with Mycobacterium tuberculosis but do not show active symptoms of the disease. Latent TB can remain dormant in the body for years, kept in check by the immune system. Identifying LTBI is crucial because these individuals carry a lifetime risk of the infection converting into active, infectious pulmonary tuberculosis. Screening is highly recommended for individuals living in high-burden regions, those with close contact history, or individuals with lifestyle factors that increase exposure risks.

2. Pre-Immunosuppressive Therapy Evaluation

Before initiating advanced medical treatments that suppress the immune system, clinicians must rule out latent tuberculosis. Therapies such as Tumor Necrosis Factor (TNF) inhibitors, high-dose corticosteroids, cancer chemotherapy, and pre-transplant immunosuppression can weaken the body’s immune surveillance. If a patient with undiagnosed latent TB begins these therapies, the dormant bacteria can rapidly replicate, leading to severe, life-threatening active systemic or miliary tuberculosis. The QFT-Plus provides a safe, highly reliable baseline screening tool before starting these treatments.

3. Healthcare Worker and Occupational Screening

Medical professionals, laboratory technicians, correctional facility staff, and individuals working in long-term care facilities are at a significantly higher risk of occupational exposure to tuberculosis. Routine screening using the QuantiFERON-TB Gold Plus test is standard protocol in modern healthcare systems. Because the test does not produce false-positive results in individuals who have received the Bacillus Calmette-Guérin (BCG) vaccine, it is the preferred screening method for healthcare workers, many of whom have been vaccinated during childhood.

4. Contact Investigation After Exposure

When an active case of pulmonary tuberculosis is diagnosed, public health authorities and clinicians conduct a contact investigation. Individuals who have shared indoor air space with the infectious patient (such as family members, classmates, or coworkers) are tested using the QFT-Plus. Because the immune system takes several weeks to mount a measurable T-cell response after exposure, the test is often performed immediately after exposure and, if negative, repeated 8 to 10 weeks later to confirm that transmission did not occur.

5. Differential Diagnosis in High-Risk Patients

In patients presenting with atypical pulmonary symptoms, chronic cough, unexplained weight loss, or persistent fever, clinicians use the QuantiFERON-TB Gold Plus test as part of a comprehensive diagnostic workup. It helps differentiate tuberculosis from other chronic lung conditions, such as sarcoidosis, fungal infections, or lung malignancies. While a positive QFT-Plus result indicates TB infection, clinicians combine this finding with sputum cultures, chest X-rays, and clinical evaluations to determine whether the infection is latent or active.

What Does a QuantiFERON-TB Gold Plus Detect?

The QuantiFERON-TB Gold Plus test detects several critical immunological parameters and clinical indicators:

• Mycobacterium tuberculosis Infection: Confirms the presence of a cellular immune response to TB proteins.
• CD4+ T-Cell Activation: Measures the helper T-cell response stimulated by the TB1 antigen tube.
• CD8+ T-Cell Activation: Measures the cytotoxic T-cell response stimulated by the TB2 antigen tube, which is highly active in controlling intracellular TB infections.
• Interferon-Gamma Release: Quantifies the exact concentration of IFN-γ in international units per milliliter (IU/mL).
• Background Interferon Levels: Uses the Nil tube to identify pre-existing, non-specific interferon in the patient’s blood.
• Immune System Competence: Uses the Mitogen tube as a positive control to verify that the patient’s immune cells are capable of responding to stimulation.
• Latent TB Status: Detects dormant tuberculosis bacteria residing within macrophages.
• Active TB Support: Provides immunological evidence supporting a clinical diagnosis of active pulmonary or extrapulmonary TB.
• Exclusion of BCG Vaccine Interference: Distinguishes true TB infection from immune responses caused by childhood BCG vaccination.
• Exclusion of Most Non-Tuberculous Mycobacteria: Avoids cross-reaction with environmental mycobacteria, except for M. kansasii, M. szulgai, and M. marinum.
• Immunosuppression-Induced Anergy: Detects when a patient’s immune system is too weak to respond, resulting in an indeterminate test.
• Recent TB Exposure: Identifies newly acquired infections during contact tracing.
• Extrapulmonary TB Support: Assists in diagnosing TB in non-pulmonary sites, such as lymph nodes, bones, or the central nervous system.
• Baseline Immunological Status: Establishes a reference point before starting biological therapies.
• Occupational Conversion: Tracks changes in immune status over time in high-exposure work environments.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The QuantiFERON-TB Gold Plus test involves a complex laboratory process, including a precise 16-to-24-hour incubation period, followed by centrifugation and a highly sensitive ELISA assay. Typically, the official diagnostic report is finalized and verified by our consultant pathologist within 24 to 48 hours of sample collection.

Patients can easily access their reports through multiple convenient channels. Once the results are verified, an automated SMS notification containing a direct secure link is sent to the patient’s registered mobile number. Reports can be viewed, downloaded, and printed directly from the Test Zone Diagnostic Center online portal. Physical copies of the reports can also be collected from our main reception desk or any of our official collection centers.

QuantiFERON-TB Gold Plus Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Nil Control Tube (Grey)	≤ 8.0 IU/mL (Low background interferon activity)	> 8.0 IU/mL (High background inflammation or technical error)
TB1 Antigen Response (Green)	< 0.35 IU/mL (No significant CD4+ T-cell response to TB)	≥ 0.35 IU/mL and ≥ 25% of Nil (Positive CD4+ response to TB)
TB2 Antigen Response (Yellow)	< 0.35 IU/mL (No significant CD4+/CD8+ T-cell response)	≥ 0.35 IU/mL and ≥ 25% of Nil (Positive CD4+ and CD8+ response)
Mitogen Control Tube (Purple)	≥ 0.5 IU/mL (Adequate immune cell responsiveness)	< 0.5 IU/mL (Indeterminate result due to cellular exhaustion or immunosuppression)
Overall Interpretation	Negative (No immunological evidence of TB infection)	Positive (TB infection detected) or Indeterminate (Inconclusive)
CD4+ Helper T-Cell Activity	Normal baseline levels	Elevated, indicating active antigen presentation and recognition
CD8+ Cytotoxic T-Cell Activity	Normal baseline levels	Elevated, suggesting robust intracellular defense against TB

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for QuantiFERON-TB Gold Plus?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly trained pathologists, microbiologists, and phlebotomists specializing in advanced immunological assays.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: We adhere to strict international laboratory standards, ensuring high precision and minimal risk of sample contamination.
• Professional Reporting: Our diagnostic reports are comprehensive, easy to read, and verified by expert clinical pathologists.
• Modern Diagnostic Approach: We utilize state-of-the-art ELISA readers and automated incubation systems for consistent, reliable results.
• Comfortable Environment: Our diagnostic center offers a clean, hygienic, and welcoming environment for all patients.
• Convenient Location: Located strategically in Lahore, Pakistan, our center is easily accessible for patients from all parts of the city.
• Commitment to Accurate Diagnosis: We employ rigorous internal and external quality control protocols to guarantee the clinical accuracy of every test.